BG Medicine to Find Biomarkers, Study Drug Effects in Deal with Boehringer Ingelheim

Jul 28, 2005

NEW YORK, July 28 (GenomeWeb News) - Using its systems pharmacology platform, BG Medicine will examine the effects of drugs in tissue and discover plasma biomarkers in an agreement with Boehringer Ingelheim Pharmaceuticals, the companies said today in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Main menu